Table 1.
Factors | n = 79 |
---|---|
Age | 63 |
Median, range | (37–86) |
Age | |
<65 | 45 (57) |
≥65 | 34 (43) |
Gender | |
Male | 47 (59.5) |
Female | 32 (40.5) |
Tumor location | |
Colon cancer | 76 (96.2) |
Rectal cancer | 3 (3.8) |
Pathologic T stage | |
Tis | 1 (1.3) |
T1 | 6 (7.6) |
T2 | 3 (3.8) |
T3 | 53 (67.1) |
T4 | 16 (20.3) |
Pathologic N stage | |
N0 | 38 (48.1) |
N1 | 20 (25.3) |
N2 | 21 (26.6) |
Pathologic Stage | |
I | 9 (4.5) |
II | 28 (35.4) |
III | 39 (49.4) |
IV | 3 (3.8) |
Differentiation | |
well | 3 (3.8) |
moderate | 53 (67.1) |
poor | 18 (22.8) |
others | 3 (3.8) |
KRAS | |
wild | 42 (53.2) |
mutant | 30 (38) |
MSI | |
low | 69 (87.3) |
high | 6 (7.6) |
Histology | |
adenocarcinoma | 78 (98.7) |
others | 1 (1.3) |
Lymphovascular invasion | |
present | 43 (54.4) |
absent | 35 (44.3) |
Venous invasion | |
present | 43 (54.4) |
absent | 32 (40.5) |
Perineural invasion | |
present | 54 (68.4) |
absent | 24 (30.4) |
lymphocyte response | |
present | 57 (72.2) |
absent | 18 (22.8) |
Recurrence | 16 (20.3) |
Death | 4 (5.1) |